Shanghai Raas Blood Products Co.,Ltd.’s Net Profit Rose 30.9% in First Half of 2021

Shanghai Raas Blood Products Co.,Ltd. (上海莱士血液制品股份有限公司) (002252.SZ) reported a net profit of 908.4 million yuan in the first half of 2021, up 30.9% year-on-year.

Meanwhile, the company posted 1.8 billion yuan in revenue, up 34.1% year-on-year.

At the end of the reporting period, it had 26.5 billion yuan in total assets and 794 million yuan in total liabilities, with a liability-to-asset ratio of 3%.

This article was automatically produced by Caixin Automation on Aug. 26, 2021.

Download our app to receive breaking news alerts and read the news on the go.

Follow the Chinese markets in real time with Caixin Global’s new stock database.